PD P 506 A applied for 0.5, 1, 2 or 4 hours in combination with red light for photodynamic therapy of mild to moderate actinic keratosis.
Phase of Trial: Phase II
Latest Information Update: 11 Jul 2011
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Therapeutic Use
- 11 Jul 2011 New trial record